TWiV explains a study of how climate change is predicted to increase cross-species viral transmission risk, and increased memory B cell potency and breadth after a SARS-CoV-2 mRNA vaccine boost.
TWiV 890: Looking into a booster crystal ball
- April 17, 2022
- Tagged as: antibody, coronavirus, COVID-19, mRNA vaccine, pandemic, SARS-CoV-2, t cells, vaccine booster, virus
This episode of TWiV is focused on COVID-19 vaccines and antibodies: who should get boosters, whether a variant matched mRNA vaccine is superior to a historical vaccine, and how the interval between vaccination and infection influences the quality of the antibody response.
TWiV 882: Elispot on about T cells and lipids
- March 31, 2022
- Tagged as: antibody, coronavirus, COVID-19, cytokine storm, IL-1, IL-1ra, inflammatory response, Moderna, mRNA vaccine, pandemic, SARS-CoV-2, t cells, viral, virology, virus, viruses
Vincent and Brianne review the need to better understand T cell responses to SARS-CoV-2 infection to better inform public health decisions, and how IL-1 and IL-1ra are important regulators of the inflammatory response to RNA vaccines.
TWiV 860: Evading a Toll on the road to RNA vaccines
- January 30, 2022
- Tagged as: coronavirus, COVID-19, mRNA vaccine, pandemic, pseurouracil, SARS-CoV-2, viral, virology, virus, viruses
TWiV reviews a seminal paper showing that chemically modified bases in RNAs suppress recognition by Toll-like receptors, a finding that that was essential for the development of COVID-19 mRNA vaccines.
Paul Offit returns to TWiV to discuss new CDC guidance on J&J vaccine, why children should be immunized against COVID-19, and whether or not booster doses are scientifically justified.
TWiV provides an update on immunity to Omicron, results of a randomized controlled trial of face masks, and a study of correlates of protection against respiratory syncytial virus infection in the upper and lower respiratory tract of nonhuman primates.
TWiV 839: The long and the short of it: get vaccinated
- December 9, 2021
- Tagged as: coronavirus, COVID-19, mRNA vaccine, Omicron, pandemic, SARS-CoV-2, vaccine dose schedule, variant of concern, viral, virology, virus, viruses
TWiV reviews the impact of vaccination on SARS-CoV-2, the latest information on Omicron, West Nile virus transmission by organ transplantation, and why a 16 week interval between doses of BNT162b2 vaccine is better than a shorter interval.
A TWiV duo reviews how SARS-CoV-2 attacks the olfactory mucosa but spares the olfactory bulb, vaccination with BNT162b2 induces virus-specific stem cell memory T cells, and development of an oral protease inhibitor for the treatment of COVID-19.
TWiV 827: A shot to save the world with Greg Zuckerman
- November 7, 2021
- Tagged as: adenovirus vector, BioNTech, coronavirus, COVID-19, Moderna, mRNA vaccine, Novavax, pandemic, Pfizer, SARS-CoV-2, Vaccine, viral, virology, virus, viruses
Greg Zuckerman joins TWiV to discuss his book that explores the race to produce COVID-19 vaccines, with insights into the companies, scientists, and executives involved and the rivalries, ambitions, ego, and a desire to save the world.
TWiV reviews how a novel technology enabled development of COVID-19 mRNA vaccines, and discovery of a proton gradient and an incomplete TCA cycle in a giant. virus.
Inside a BSL-4
